Literature DB >> 12203777

Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization.

Yann-Jang Chen1, Pei-Jer Chen, Mei-Chi Lee, Shiou-Hwei Yeh, Ming-Ta Hsu, Chi-Hung Lin.   

Abstract

Hepatic adenoma (HA) and focal nodular hyperplasia (FNH) are two common non-malignant tumors of the liver. Genomic analysis on these benign lesions may shed light on the genetic mechanism underlying liver carcinogenesis. We used comparative genomic hybridization (CGH) to evaluate genomic changes in eight cases of HA and six cases of FNH, obtained by surgical procedures; the resulting chromosomal aberration profiles were analyzed together with their pathological and clinical manifestations. We found consistent chromosomal lesions associated with both non-malignant hepatic tumors. The overall genomic abnormalities in HA and FNH were much less obvious than those in hepatocellular carcinoma (HCC). Among these limited changes, frequent gains were located on chromosomal arms 1q (50%), 17q (50%), 1p (38%), and 11q (38%) in HA, and on 11q (50%), 9q (33%), 17q (33%), and 22q (33%) in FNH. Gains outnumbered losses, and HA contained more CGH abnormalities than did FNH. Interestingly, CGH alteration hotspots found in HA, but not in FNH, appeared largely to coincide with common genomic lesions of cancerous HCC, suggesting an interesting relationship along the tumorigenesis pathway of HA and HCC. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12203777     DOI: 10.1002/gcc.10103

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  10 in total

Review 1.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

Review 2.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

Review 3.  [Hepatocellular adenoma. Malignancy potential and differentiation from hepatocellular carcinoma].

Authors:  P Flemming; U Lehmann; D Steinemann; H Kreipe; L Wilkens
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

4.  Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report.

Authors:  Caner Ercan; Mairene Coto-Llerena; John Gallon; Lana Fourie; Mattia Marinucci; Gabriel F Hess; Jürg Vosbeck; Stephanie Taha-Mehlitz; Tuyana Boldanova; Marie-Anne Meier; Alexandar Tzankov; Matthias S Matter; Martin H K Hoffmann; Luca Di Tommaso; Markus von Flüe; Charlotte K Y Ng; Markus H Heim; Savas D Soysal; Luigi M Terracciano; Otto Kollmar; Salvatore Piscuoglio
Journal:  Commun Med (Lond)       Date:  2022-02-03

5.  Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis.

Authors:  S-H Zhang; W-M Cong; M-C Wu
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

6.  Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.

Authors:  Yi-Ran Cai; Li Gong; Xiao-Ying Teng; Hong-Tu Zhang; Cheng-Feng Wang; Guo-Lian Wei; Lei Guo; Fang Ding; Zhi-Hua Liu; Qin-Jing Pan; Qin Su
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

7.  Monitoring the growth effect of xenotransplanted human medulloblastoma in an immunocompromised mouse model using in vitro and ex vivo green fluorescent protein imaging.

Authors:  Shih-Hwa Chiou; Chung-Lan Kao; Han-Tso Lin; Wen-Ser Tseng; Ren-Shyan Liu; Chen-Fun Chung; Hung-Hai Ku; Ching-Po Lin; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2006-03-16       Impact factor: 1.475

8.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.

Authors:  Jian Hong; Kaishun Hu; Yunfei Yuan; Yi Sang; Qiangui Bu; Guihua Chen; Longjun Yang; Binkui Li; Pinzhu Huang; Dongtai Chen; Yi Liang; Ruhua Zhang; Jingxuan Pan; Yi-Xin Zeng; Tiebang Kang
Journal:  J Clin Invest       Date:  2012-05-15       Impact factor: 14.808

10.  Molecular classification of hepatocellular adenomas.

Authors:  Jean Charles Nault; Jessica Zucman Rossi
Journal:  Int J Hepatol       Date:  2013-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.